Lassogen, Inc. logo
Lassogen, Inc. logo

Lassogen, Inc.

lassogen.com
lassogen.com • HQ: San Diego, United States • Venture - Series Unknown 2020 • 11-50 employees • Founded 2019 • Startup • New
HQ: San Diego, United States • Venture - Series Unknown 2020 • 11-50 employees • Founded 2019 • Startup • New
Actively hiring
Food & Beverages
Biotechnology
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$5.1M
1 round on record
Latest round
$5.1M
Venture round · Sep 2020 · 6 yr ago
Team
11-50
employees, estimated range
Backers
1
Better Ventures
The money's age
Long since its last round
72 months since the last round · not hiring
Momentum
0/100
no fresh signals
Funding rounds
RoundDateAmountInvestorsSource
Venture round Sep 2020 $5.1M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Lassogen, Inc. sec
Founders and leadersfrom filings, registers and the company's site
Mark BurkExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Better Ventures fund
Similar startupsby what they do, their industry and backers
ADCytherix
Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need…
Kinaset TherapeuticsVenture round $28.5M · 4 yr ago • Founded 2020 • 51-200 employees
DEVELOPING INHALED THERAPEUTICS IN RESPIRATORY DISEASES. Kinaset is developing KN-002 to treat all patients with severe asthma regardless…
EvozyneVenture round $81M · 3 yr ago • Founded 2019 • 201-500 employees
ABOUT US Our Mission To design and build engineered protein therapeutics with our AI-native platform, transforming what's possible in…
Draupnir Bio
Draupnir Bio is developing new innovative therapies for patients.
Cullinan Therapeutics
Committed to developing high-impact and differentiated therapies, with a focus on building a robust autoimmune disease and cancer pipeline…
Octagon TherapeuticsVenture round $11M · 2 yr ago • Founded 2016 • 11-50 employees
A biotech company developing better medicines for patients with autoimmune and inflammatory diseases. Leveraging powerful insights into the…

Overview

Lassogen is developing a new therapeutic modality based on lasso peptides that we are programming to treat difficult diseases such as cancer and autoimmune ...

People

Mark Burk
Executive Officer
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Diego United States
HQ
San Diego Science Center3030 Bunker Hill Street, Suite 220 San Diego, CA 92109
10-50 est. staff
3030 Bunker Hill Street, Suite 220, San Diego, CA 92109
company site

Financials

Total raised
$5.1M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2020 $5.1M Details